Sponsor pipeline

Perspective Therapeutics clinical trial pipeline

Get alerts when Perspective Therapeutics's trials change

3 active trials 3 recruiting 9 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1/2
3

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT06710756 Lead-212 PSV359 Therapy for Patients With Solid Tumors Pancreatic Ductal Adenocarcinoma Recruiting 2026-10-07
NCT05655312 MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in… Recurrent Melanoma (Skin) Recruiting 2026-06-10
NCT05636618 Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2)… Neuroendocrine Tumors Unresectable Recruiting 2026-05-14

Disease areas by active trials

Colorectal Cancer (1) · Esophageal Cancer (1) · Gastric Cancer (1) · Head & Neck Cancer (1) · Melanoma (1) · Mesothelioma (1) · Ovarian Cancer (1) · Pancreatic Cancer (1) · Sarcoma (1)

Get alerts when Perspective Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free